Moderna (MRNA) Reports Q1 Earnings: What Key Metrics Have to Say

Moderna (MRNA) reported $108 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 35.3%. EPS of -$2.52 for the same period compares to -$3.07 a year ago.The reported revenue represents a surprise of -14.95% over the Zacks Consensus Estimate of $126.98 million. With the consensus EPS estimate being -$2.92, the EPS surprise was +13.70%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine ...